Skip to main content

Merck & Co., Inc. cash flow statement

  • MRK · NYSE
  • Pharmaceuticals
  • S&P 500
$147.76+0.55%Close 13 Nov 2026 · Market value $361.6B

In fiscal 2025 (the year to 31 Dec 2025), Merck & Co., Inc. generated $16.47B of operating cash flow and $12.36B of free cash flow, after $4.11B of capital expenditure.

From Merck & Co., Inc.'s annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

Merck & Co., Inc. cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$3.28B$7.81B$12.90B$861.0M$6.27B$6.17B$4.40B$11.92B$4.44B$3.92B$2.39B$6.22B$9.84B$7.07B$13.05B$14.52B$365.0M$17.12B$18.25B$2.45B
Depreciation & amortization$1.99B$1.63B$2.58B$7.38B$7.43B$6.98B$6.99B$6.69B$6.38B$5.47B$4.68B$4.52B$3.65B$3.47B$3.24B$3.88B$3.83B$4.50B$5.84B—
Stock-based compensation$330.2M$348.0M$415.0M$509.0M$369.0M$335.0M$276.0M$278.0M$299.0M$300.0M$312.0M$348.0M$388.0M$441.0M$479.0M$541.0M$645.0M$761.0M$820.0M$1.06B
Operating cash flow$7.00B$6.57B$3.39B$10.82B$12.38B$10.02B$11.65B$7.99B$12.54B$10.38B$6.45B$10.92B$8.88B$7.62B$14.11B$19.09B$13.01B$21.47B$16.47B$18.70B
Operating cash flow margin28.9%27.6%12.4%23.5%25.8%21.2%26.5%18.9%31.7%26.1%16.1%25.8%22.7%18.3%29.0%32.2%21.6%33.5%25.3%27.8%
Capital expenditures$1.01B$1.30B$1.46B$1.68B$1.72B$1.95B$1.55B$1.32B$1.28B$1.61B$1.89B$2.62B$3.37B$4.43B$4.45B$4.39B$3.86B$3.37B$4.11B$3.96B
Acquisitions$1.14B$0.00$130.0M$256.0M$373.0M$0.00$246.0M$181.0M$146.0M$780.0M$396.0M$431.0M$294.0M$1.36B$179.0M$121.0M$0.00$746.0M$10.04B$18.82B
Free cash flow$5.99B$5.27B$1.93B$9.14B$10.66B$8.07B$10.11B$6.67B$11.26B$8.76B$4.56B$8.31B$5.51B$3.19B$9.66B$14.71B$9.14B$18.10B$12.36B$14.75B
Free cash flow margin24.7%22.1%7.0%19.9%22.2%17.1%23.0%15.8%28.5%22.0%11.4%19.6%14.1%7.7%19.8%24.8%15.2%28.2%19.0%21.9%
Free cash flow per share$2.72$2.46$0.85$2.93$3.45$2.62$3.37$2.28$3.96$3.14$1.66$3.10$2.14$1.25$3.81$5.79$3.59$7.12$4.93$5.95
Dividends paid$3.31B$3.28B$3.21B$4.73B$4.69B$5.12B$5.16B$5.17B$5.12B$5.12B$5.17B$5.17B$5.70B$6.21B$6.61B$7.01B$7.45B$7.84B$8.18B$8.37B
Gross share repurchases$1.43B$2.73B$0.00$1.59B$1.92B$2.59B$6.52B$7.70B$4.19B$3.43B$4.01B$9.09B$4.78B$1.28B$840.0M$0.00$1.35B$1.31B$5.08B$3.54B
Stock issuance proceeds$898.6M$102.0M$186.0M$363.0M$321.0M$1.31B$1.21B$1.56B$485.0M$939.0M$499.0M$591.0M$361.0M$89.00M$202.0M$384.0M$125.0M$177.0M$92.00M$494.0M
Net share repurchases$531.1M$2.62B−$186.0M$1.23B$1.60B$1.28B$5.31B$6.14B$3.70B$2.50B$3.52B$8.50B$4.42B$1.19B$638.0M−$384.0M$1.22B$1.13B$4.99B$3.04B
Cash interest paid—$247.0M$351.0M$763.0M$600.0M$808.0M$922.0M$852.0M$653.0M$686.0M$723.0M$777.0M$841.0M$822.0M$779.0M$937.0M$1.10B$1.30B$1.30B—
Free cash flow after SBC$5.66B$4.93B$1.52B$8.63B$10.29B$7.73B$9.83B$6.39B$10.96B$8.46B$4.25B$7.96B$5.13B$2.75B$9.18B$14.17B$8.50B$17.34B$11.54B$13.69B

Quarterly

Merck & Co., Inc. cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income−$1.23B$4.76B$5.46B$3.16B$3.74B$5.08B$4.43B$5.79B$2.96B−$4.24B−$1.33B$5.07B
Depreciation & amortization—————————$1.02B$1.07B$1.14B
Stock-based compensation$167.0M$176.0M$203.0M$195.0M$187.0M$195.0M$216.0M$204.0M$205.0M$185.0M$298.0M$369.0M
Operating cash flow$246.0M$3.09B$5.64B$9.29B$3.45B$2.50B$3.29B$7.82B$2.86B$3.92B$5.37B$6.56B
Operating cash flow margin1.7%19.6%35.0%55.8%22.1%16.1%20.8%45.3%17.4%24.1%32.3%36.3%
Capital expenditures$989.0M$861.0M$791.0M$783.0M$937.0M$1.33B$764.0M$987.0M$1.03B$991.0M$893.0M$1.04B
Acquisitions$0.00$746.0M$0.00$598.0M$598.0M$0.00$0.00$0.00$10.04B$8.78B$0.00$0.00
Free cash flow−$743.0M$2.23B$4.85B$8.51B$2.51B$1.17B$2.53B$6.83B$1.82B$2.93B$4.48B$5.52B
Free cash flow margin−5.1%14.1%30.1%51.1%16.1%7.5%16.0%39.6%11.1%18.0%27.0%30.5%
Free cash flow per share−$0.29$0.88$1.90$3.35$0.99$0.46$1.01$2.74$0.73$1.18$1.81$2.23
Dividends paid$1.85B$1.95B$1.99B$1.95B$1.95B$2.05B$2.08B$2.03B$2.02B$2.10B$2.14B$2.10B
Gross share repurchases$393.0M$122.0M$251.0M$444.0M$489.0M$1.16B$1.34B$1.32B$1.25B$874.0M$757.0M$653.0M
Stock issuance proceeds$6.00M$87.00M$73.00M$5.00M$12.00M$19.00M$12.00M$14.00M$47.00M$157.0M$43.00M$247.0M
Net share repurchases$387.0M$35.00M$178.0M$439.0M$477.0M$1.15B$1.33B$1.31B$1.21B$717.0M$714.0M$406.0M
Cash interest paid$422.0M$217.0M$364.0M$241.0M$478.0M$233.0M$383.0M$233.0M$451.0M$342.0M$654.0M—
Free cash flow after SBC−$910.0M$2.05B$4.64B$8.31B$2.33B$977.0M$2.31B$6.63B$1.62B$2.74B$4.18B$5.15B

The main figures as JSON and plain text. See data and methodology.

MRK in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.